HealthDay on MSN59m
American Cancer Society Calls for Restoration of Key CDC, FDA Data
With certain government data currently being withheld, removed, or restored but partially redacted on the websites of ...
OS Therapies gears up for FDA meeting on cancer drug
NEW YORK - OS Therapies, Inc. (NYSE-A: OSTX), a small-cap biotech firm with a market capitalization of $42 million focusing on cancer treatment solutions, has announced the completion of its Phase 2b ...
Cure Today11d
Breaking Down Cancer Therapies Approved by the FDA in January 2025
Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...
FDA’s plan to propose ban on formaldehyde in hair-straightening products remains in limbo under Trump administration
A plan for the US Food and Drug Administration to propose banning formaldehyde and certain formaldehyde-releasing chemicals ...
'I'm not normal anymore': Hair stylist sues companies over link between hair dye and cancer
Occupational studies stretching back decades have found an increased risk of bladder cancer among hairdressers.
STAT4h
Corbus reports first Western data for closely tracked ADC cancer drug
Corbus Pharmaceuticals presented new data from the first Western study of its antibody-drug conjugate treatment for cancer.
Healio6h
Direct-to-consumer genetic testing for cancer predisposition can have ‘pitfalls’
Genomic cancer predisposition tests should be done with professional counseling, and the FDA should implement safeguards for ...
Hartford Business2d
FDA approves CT drugmaker’s therapy for rare cancer tumors
Stamford-based SpringWorks Therapeutics, a commercial-stage biotech company developing treatments for rare diseases and ...
Cure Today3d
Breaking Down the FDA Labeling Update of Xeloda and 5-FU in Cancer Care
The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...
Targeted Oncology8d
FDA Grants Key Oncology Approvals and Designations in January 2025
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
Why Is Blood Cancer Focused Moleculin Biotech Stock Trading More Than 400% On Thursday?
Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...
Targeted Oncology3d
FDA Grants 510(k) Clearance to Ibex Prostate Detect AI for Prostate Cancer
The FDA has granted a 510 (k) clearance to the Ibex Prostate Detect software (formerly Galen Second Read). The Ibex Prostate ...